Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Stock Information for Hyperfine Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Hyperfine Inc.

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
Hyperfine Announces Regulatory Approval of the Swoop® System in India
Hyperfine Announces FDA Clearance of the First Optive AI(TM) Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.